Issue Date: March 2, 1998
Issued by: Center for Drug Evaluation and Research
Topic(s): Clinical – Medical
Status: Final
Guidance for the Development of Vaginal Contraceptive Drugs (NDA)
The FDA published Good Guidance Practices in February 1997. This guidance was developed and issued prior to that date.
Download the Guidance Document
